Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Presenilin function in APP processing.

W Annaert1, P Cupers, P Saftig

  • 1Center for Human Genetics, Flanders Interuniversitary Institute for Biotechnology, Gasthuisberg, KULeuven, Leuven, Belgium.

Annals of the New York Academy of Sciences
|February 24, 2001
PubMed
Summary

Familial Alzheimer's disease (FAD) involves APP and presenilin gene mutations. Researchers hypothesize these genes are also key players in sporadic Alzheimer's disease (AD) due to shared neuropathology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atypical chemokine receptor 3 regulates synaptic removal in disease astrocytes.

Molecular neurodegeneration·2026
Same author

CTAD taskforce: genetic therapies in Alzheimer's disease.

The journal of prevention of Alzheimer's disease·2025
Same author

Identification and in vivo characterization of a brain-penetrating nanobody.

Fluids and barriers of the CNS·2020
Same author

Screening and Characterization Strategies for Nanobodies Targeting Membrane Proteins.

Methods in enzymology·2017
Same author

Serum Starvation Induces BACE1 Processing and Secretion.

Current Alzheimer research·2016
Same author

The Parkinson's gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes.

Oncogene·2014

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Familial Alzheimer's disease (FAD) is linked to mutations in amyloid precursor protein (APP) and presenilin genes.
  • These FAD-related mutations account for only 0.1% of all Alzheimer's disease (AD) cases.
  • The etiology of the 99.9% of sporadic AD cases remains largely unknown.

Purpose of the Study:

  • To investigate the potential role of APP and presenilin genes in both familial and sporadic Alzheimer's disease.
  • To explore the underlying molecular pathogenic mechanisms common to FAD and sporadic AD.
  • To deepen the understanding of the fundamental neurobiology of APP and presenilins.

Main Methods:

  • Review of genetic links to FAD (APP, presenilin 1, presenilin 2).

Related Experiment Videos

  • Comparison of neuropathological features between FAD and sporadic AD.
  • Hypothesis formulation based on shared disease characteristics.

    • Main Results:

    • FAD is associated with mutations in APP (chromosome 21) and presenilin 1/2 (chromosomes 14/1).
    • Presenilin mutations are more frequent in FAD cases than APP mutations.
    • FAD and sporadic AD share key neuropathological hallmarks like cognitive impairment, amyloid plaques, and neurofibrillary tangles.

    Conclusions:

    • APP and presenilins are hypothesized to be critical players in the pathogenesis of both familial and sporadic Alzheimer's disease.
    • Understanding the cell biology of APP and presenilins offers insight into AD pathology.
    • This research highlights the importance of these proteins in neurobiology and AD.